• LABline
  • Magazine Archive
  • Webinars
  • Whitepapers
  • eBooks
  • Videos
  • Subscribe
    • ID 61156402 © Vitaliy Smolygin | Dreamstime.com
    dreamstime_xxl_61156402
    Genomics

    The genetics of aggressive prostate cancer

    Erin Brady
    March 5, 2025
    A new prostate cancer discovery answers why certain cases are more deadly than others. UCLA, the University of Toronto, and the University of Melbourne researchers “used...
    By Tahsin on Adobe Stock
    adobestock_919184766
    ID 141702959 © Ustyna Shevhcuk | Dreamstime.com
    dreamstime_xxl_141702959
    By Fokasu Art on Adobe Stock
    adobestock_922267230
    ID 309524910 © Julija Matuka | Dreamstime.com
    dreamstime_xxl_309524910_1
    ID 309524910 © Julija Matuka | Dreamstime.com
    dreamstime_xxl_309524910
    ID 335137467 © Dzmitry Auramchik | Dreamstime.com
    dreamstime_xxl_335137467
    Genetic Testing

    Can genetic testing predict opioid use disorder risk?

    Erin Brady
    Jan. 10, 2025
    Study from the University of Pennsylvania Perelman School of Medicine and Crescenz VA Medical Center.
    ID 3592783 © Vividpixels | Dreamstime.com
    dreamstime_xxl_3592783
    Genomics

    Genomics England select QIAGEN’s Clinical Knowledge Base to power whole-genome sequencing study for newborns

    LABline
    Jan. 9, 2025
    National study will screen newborns for more than 200 treatable conditions.
    ID 335593682 | Ai Dna © Doberman84 | Dreamstime.com
    dreamstime_xxl_335593682
    Molecular

    Study uses two sequencing methods to discover new mRNAs in neurodegenerative diseases

    LABline
    Dec. 23, 2024
    New study findings from Sanford Burnham Prebys could pave the way for future treatments for neurodegenerative diseases. The research was led by Jerold Chun MD, PhD, and published...
    ID 141973761 © Vetre Antanaviciute-meskauskiene | Dreamstime.com
    dreamstime_xxl_141973761
    Precision Medicine

    Personalized care for children with NDD

    Erin Brady
    Dec. 20, 2024
    A new UCLA study on genetic testing.
    Courtesy of Roche Diagnostics
    product_ins_6728_im_en
    Molecular

    Roche launches cobas Mass Spec solution

    LABline
    Dec. 19, 2024
    cobas Mass Spec solution will offer a fully automated, integrated and standardized workflow with IVDR-compliant assays.
    Courtesy of Thermo Fisher Scientific
    thumbnail_image001
    DNA/RNA

    Thermo Fisher Scientific introduces MagMAX Sequential DNA/RNA Kit

    LABline
    Dec. 18, 2024
    Product to help advance and accelerate hematological cancer research.
    ID 211428312 © Andrei Ivanov | Dreamstime.com
    dreamstime_xxl_211428312
    MDX

    Fluxergy announces NIAID collaboration

    LABline
    Nov. 21, 2024
    This announcement follows the news of a previous partnership launched earlier this year for Fluxergy.
    ID 208710288 © Noipornpan | Dreamstime.com
    dreamstime_xxl_208710288
    Genomics

    UW–Madison researchers find persistent problems with AI-assisted genomic studies

    LABline
    Nov. 6, 2024
    The faulty predictions are linked to researchers’ use of AI to assist genome-wide association studies.

    Molecular

    ID 322970799 © Leo Rohmann | Dreamstime.com
    dreamstime_xxl_322970799
    ID 338975729 © Pakawadee Wongjinda | Dreamstime.com
    dreamstime_xxl_338975729
    ID 88421052 © Mkarco | Dreamstime.com
    dreamstime_xxl_88421052
    ID 332220455 | Ai © Dzmitry Auramchik | Dreamstime.com
    dreamstime_xxl_332220455
    ID 330693766 © Mast3r | Dreamstime.com
    dreamstime_xxl_330693766
    ID 127325015 © Dani3315 | Dreamstime.com
    dreamstime_xxl_127325015
    ID 99439237 © gopixa | Dreamstime.com
    dreamstime_xxl_99439237